BC Perception Holdings LP 13D and 13G filings for Cerevel Therapeutics Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-08-05 4:30 pm Sale | 2024-08-01 | 13D | Cerevel Therapeutics Holdings, Inc. CERE | BC Perception Holdings LP | 0 0.000% | -65,679,781 (Position Closed) | Filing |
| 2023-12-08 5:00 pm Unchanged | 2023-12-06 | 13D | Cerevel Therapeutics Holdings, Inc. CERE | BC Perception Holdings LP | 65,679,781 36.400% | 0 (Unchanged) | Filing |
| 2023-10-18 4:32 pm Purchase | 2023-10-16 | 13D | Cerevel Therapeutics Holdings, Inc. CERE | BC Perception Holdings LP | 65,679,781 36.500% | 5,047,425 (+8.32%) | Filing |
| 2022-08-18 4:30 pm Unchanged | 2022-08-16 | 13D | Cerevel Therapeutics Holdings, Inc. CERE | BC Perception Holdings LP | 60,632,356 38.900% | 0 (Unchanged) | Filing |
| 2022-03-03 4:52 pm Unchanged | 2022-03-01 | 13D | Cerevel Therapeutics Holdings, Inc. CERE | BC Perception Holdings LP | 60,632,356 41.000% | 0 (Unchanged) | Filing |
| 2021-07-09 5:05 pm Purchase | 2021-07-07 | 13D | Cerevel Therapeutics Holdings, Inc. CERE | BC Perception Holdings LP | 60,632,356 42.900% | 332,293 (+0.55%) | Filing |
| 2020-11-04 4:45 pm Purchase | 2020-10-27 | 13D | Cerevel Therapeutics Holdings, Inc. CERE | BC Perception Holdings LP | 60,300,063 47.400% | 60,300,063 (New Position) | Filing |